BPGAM
BOLD

BTG Pactual Global Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

BTG Pactual Global Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-61,196
Closed -$3.66M – 160
2019
Q4 		$3.66M Buy
+61,196
New +$2.3M 0.6% 47

BTG Pactual Global Asset Management's BOLD Position: Q1 2020 in Review

BTG Pactual Global Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 61,196 shares — an estimated $3.66M sold.

BTG Pactual Global Asset Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $3.66M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • BTG Pactual Global Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 61,196 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $3.66M.
  • BTG Pactual Global Asset Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's Audentes Therapeutics, Inc position peaked at $3.66M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on BTG Pactual Global Asset Management's 13F filing for Q1 2020, filed 12 May 2020.